4//SEC Filing
Brister Mark 4
Accession 0001214659-19-004750
CIK 0001427570other
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 4:30 PM ET
Size
5.9 KB
Accession
0001214659-19-004750
Insider Transaction Report
Form 4
Brister Mark
VP of Research and Development
Transactions
- Award
Stock Option (Right to Buy)
2019-07-23+35,000→ 35,000 totalExercise: $0.96Exp: 2029-07-23→ Common Stock (35,000 underlying)
Footnotes (2)
- [F1]Subject to the grantee's continued status as a service provider with the Issuer through the applicable vesting date, the option shall vest as to 100% of the shares underlying the option on the day following the filing date of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2019, based on the achievement of performance goals on or prior to December 31, 2019.
- [F2]Share amounts do not reflect the impact of a 1-for-10 reverse stock split that became effective after the grant date for the options referenced herein.
Documents
Issuer
OBALON THERAPEUTICS INC
CIK 0001427570
Entity typeother
Related Parties
1- filerCIK 0001323223
Filing Metadata
- Form type
- 4
- Filed
- Jul 24, 8:00 PM ET
- Accepted
- Jul 25, 4:30 PM ET
- Size
- 5.9 KB